Samsung shares climb more than 7% after surprise $7 billion buyback plan

Samsung shares climb more than 7% after surprise  billion buyback plan


A Samsung Group flag flutters in front of the company’s Seocho building in Seoul. 

Sopa Images | Lightrocket | Getty Images

Shares of Samsung Electronics jumped on Monday after the company unveiled a surprise plan to buy back about 10 trillion South Korean won ($7.19 billion) worth of its own stock over the next 12 months.

The South Korean tech giant’s stock rose more than 7% in Seoul, after shares had already surged 7.21% on Friday, following news that the company reached a preliminary agreement with its largest workers union, which went on strike in July.

Samsung last bought back shares in November 2017, according to data maintained by LSEG.

In a regulatory filing, the company said that 3 trillion won of shares will be bought back in the next three months and canceled. While the repurchase of the remaining 7 trillion won worth of shares will be “authorized accordingly by the Board, which will decide on ways to enhance shareholder value, including when and how to use the treasury shares,” it added.

Shares of Samsung had hit a four year low on November 15, after the company posted a disappointing profit guidance for its third quarter and amid worries about tariffs after U.S. President-elect Donald Trump won the presidential election.

The company has fallen behind rival SK Hynix in the race to supply high bandwidth memory, or HBM chips, that are a key component used by AI leader Nvidia, with analysts telling CNBC that “it is fair to say that Samsung has not been able to close the gap with SK Hynix on the HBM development roadmap.”

HBM is a type of dynamic random access memory, known as DRAM. DRAM is often used in laptops, workstations and PCs.

According to South Korean media, SK Hynix is the first chipmaker in the world to supply fifth-generation HBM3E chips in March to Nvidia.

— CNBC’s Arjun Kharpal contributed to this report.



Source

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson’s treatment
World

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson’s treatment

Kelvn | Istock | Getty Images Shares of Japanese drugmaker Sumitomo Pharma fell over 12% Friday on what appeared to be profit-taking, a day after the government endorsed the company’s iPS cell-based therapy for Parkinson’s and heart disease. The decision is a milestone in Japan’s years-long effort to cultivate a homegrown sector focused on cutting-edge […]

Read More
Japan inflation falls below BOJ’s 2% target for first time since March 2022
World

Japan inflation falls below BOJ’s 2% target for first time since March 2022

Shop owners of a 70-year-old “takoyaki”, or octopus balls, restaurant chat while cooking along a street in the Taito Ward area of Tokyo on February 21, 2025. Richard A. Brooks | Afp | Getty Images Japan’s headline inflation rate fell to 1.5% in January, its lowest level since March 2022. The reading ended a run […]

Read More
CNBC Daily Open: Private credit fears and U.S.-Iran tensions pressure Wall Street
World

CNBC Daily Open: Private credit fears and U.S.-Iran tensions pressure Wall Street

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Feb. 19, 2026. Brendan McDermid | Reuters U.S. markets had a shaky Thursday, pressured by Washington’s escalating tensions with Iran and renewed worries over private credit. White House press secretary Karoline Leavitt said Wednesday that there were “many […]

Read More